Advertisement
Review| Volume 71, ISSUE 4, P320-325, April 2012

Primary ovarian insufficiency: Relation to changes in body composition and adiposity

      Abstract

      There are several causes of primary ovarian insufficiency (POI) but all result in a premature cessation of female reproductive potential, mimicking the normal menopause. In normal menopause, there is increased cardiovascular risk associated with changes in body composition (specifically increasing adiposity). We sought to review the literature on POI in relation to changes in adiposity and related cardiometabolic risk factors. We conclude that POI patients are usually less obese than reference groups.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Maturitas
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Verhaeghe J.
        Hormonal contraception in women with the metabolic syndrome: a narrative review.
        Eur J Contracept Reprod Health Care. 2010; 15: 305-313
        • Stevenson J.C.
        Metabolic effects of hormone replacement therapy.
        J Br Menopause Soc. 2004; 10: 157-161
        • Morabia A.
        • Costanza M.
        • The World Health Organization Collaborative Study of Neoplasia and Steroid Contraceptives
        International variability in ages at menarche, first livebirth, and menopause.
        Am J Epidemiol. 1998; 148: 1195-1205
        • De Vos M.
        • Devroey P.
        • Fauser B.C.
        Primary ovarian insufficiency.
        Lancet. 2010; 376: 911-921
        • Knauff E.
        • Eijkemans M.
        • Lambalk C.
        • ten Kate-Booij M.
        • Hoek A.
        • Beerendonk C.
        • et al.
        Anti-mullerian hormone, inhibin B, and antral follicle count in young women with ovarian failure.
        J Clin Endocrinol Metab. 2009; 94: 786-792
        • Nelson L.M.
        Primary ovarian insufficiency.
        N Engl J Med. 2009; 360: 606-614
        • Coulam C.
        • Adamson S.
        • Annegers J.
        Incidence of premature ovarian failure.
        Obstet Gynecol. 1986; 67: 604
        • Goswami D.
        • Conway G.S.
        Premature ovarian failure.
        Horm Res. 2007; 68: 196-202
        • Shelling A.N.
        Premature ovarian failure.
        Reproduction. 2010; 140: 633-641
        • Rebar R.
        • Connolly H.
        Clinical features of young women with hypergonadotropic amenorrhea.
        Fertil Steril. 1990; 53: 804-810
        • Burton K.A.
        • Ee V.A.N.
        • Purcell C.C.
        • Winship I.
        • Shelling A.N.
        Autosomal translocation associated with premature ovarian failure.
        J Med Genet. 2000; 37: e1-e2
        • Davison R.M.
        • Fox M.
        • Conway G.S.
        Mapping of the POF1 locus and identification of putative genes for premature ovarian failure.
        Mol Hum Reprod. 2000; 6: 314-318
        • Persani L.
        • Rossetti R.
        • Cacciatore C.
        • Bonomi N.
        Primary ovarian insufficiency: X chromosome defects and autoimmunity.
        J Autoimmun. 2009; 33: 35-41
        • Conway G.S.
        • Payne N.N.
        • Webb J.
        • Murray A.
        • Jacobs P.A.
        Fragile X permutation screening in women with premature ovarian failure.
        Hum Reprod. 1998; 13: 1184-1187
        • Woad K.J.
        • Watkins W.J.
        • Prendergast D.
        • Shelling A.N.
        The genetic basis of premature ovarian failure.
        Aust N Z J Obstet Gynaecol. 2006; 46: 242-244
        • Metwally M.
        • Ledger W.
        • Li T.C.
        Reproductive endocrinology and clinical aspects of obesity in women.
        Ann N Y Acad Sci. 2008; 1127: 140-146
        • Coppack S.W.
        Adipose tissue changes in obesity.
        Biochem Soc Trans. 2005; 33: 1049-1052
        • Vaidya D.
        • Becker D.M.
        • Bittner V.
        • Mathias R.A.
        • Ouyang P.
        Ageing, menopause, and ischaemic heart disease mortality in England, Wales, and the United States: modelling study of national mortality data.
        BMJ. 2011; 343: d5170https://doi.org/10.1136/bmj.d5170
        • Sieminska L.
        • Cichon-Lenart A.
        • Kajdaniuk D.
        • Kos-Kudła B.
        • Marek B.
        • Lenart J.
        • et al.
        Sex hormones and adipocytokines in postmenopausal women.
        Pol Merkuriusz Lek. 2006; 20: 727-730
        • Ferraro R.
        • Lillioja S.
        • Fontvieille A.M.
        • Rising R.
        • Bogardus C.
        • Ravussin E.
        Lower sedentary metabolic rate in women compared with men.
        J Clin Invest. 1992; 90: 780-784
        • Schwartz M.W.
        • Woods S.C.
        • Seeley R.J.
        • Barsh G.S.
        • Baskin D.G.
        • Leibel R.L.
        Is the energy homeostasis system inherently biased toward weight gain?.
        Diabetes. 2003; 52: 232-238
        • Speroff L.
        • Fritz M.A.
        Obesity.
        seventh ed. Lipincott Williams & Wilkins, Philadelphia, PA2005
        • Mantzoros C.
        • Petridou E.
        • Dessypris N.
        • Chavelas C.
        • Dalamaga M.
        • Alexe D.M.
        • et al.
        Adiponectin and breast cancer risk.
        J Clin Endocrinol Metab. 2004; 89: 1102-1107
        • Dal Maso L.
        • Augustin L.S.
        • Karalis A.
        • Talamini R.
        • Franceschi S.
        • Trichopoulos D.
        • et al.
        Circulating adiponectin and endometrial cancer risk.
        J Clin Endocrinol Metab. 2004; 89: 1160-1163
        • Michalakis K.
        • Williams C.J.
        • Mitsiades N.
        • Blakeman J.
        • Balafouta-Tselenis S.
        • Giannopoulos A.
        • et al.
        Serum adiponectin concentrations and tissue expression of adiponectin receptors are reduced in patients with prostate cancer: a case control study.
        Cancer Epidemiol Biomarkers Prev. 2007; 16: 308-313
        • Ahima R.S.
        • Flier J.S.
        Adipose tissue as an endocrine organ.
        TEM. 2000; 11: 327-333
        • Wajchenberg B.L.
        Subcutaneous and visceral adipose tissue: their relation to metabolic syndrome.
        Endocr Rev. 2000; 21: 697-738
        • Flier J.S.
        Obesity wars: molecular progress confronts an expanding epidemic.
        Cell. 2004; 116: 337-350
        • Miner J.L.
        The adipocyte as an endocrine cell.
        J Anim Sci. 2004; 82: 935-941
        • Barinaga M.
        “Obese” protein slims mice.
        Science. 1995; 269: 475-476
        • Moschos S.
        • Chan J.L.
        • Mantzoros C.S.
        Leptin and reproduction: a review.
        Fertil Steril. 2002; 77: 433-444
        • Mitchell M.
        • Armstrong D.T.
        • Robker R.L.
        • Norman R.J.
        Adipokines: implications for female fertility and obesity.
        Reproduction. 2005; 130: 583-597
        • Budak E.
        • Sanchez M.F.
        • Bellver J.
        • Cervero A.
        • Simon C.
        • Pellicer A.
        Interactions of the hormones leptin, ghrelin, adiponectin, resistin and PYY3-36 with the reproductive system.
        Fertil Steril. 2006; 86: 1563-1581
        • Gravholt C.H.
        Epidemiological, endocrine and metabolic features in Turner syndrome.
        Eur J Endocrinol. 2004; 151 (Review): 657-687
        • Chapman R.M.
        Effect of cytotoxic therapy on sexuality and gonadal function.
        Semin Oncol. 1982; 9: 84-94
        • Franklin R.M.
        • Ploutz-Snyder L.
        • Kanaley J.A.
        Longitudinal changes in abdominal fat distribution with menopause.
        Metabolism. 2009; 58: 311-315
        • Deecher D.C.
        • Dorries K.
        Understanding the pathophysiology of vasomotor symptoms (hot flushes and night sweats) that occur in perimenopause, menopause, and postmenopause life stages.
        Arch Womens Ment Health. 2007; 10 ([Epub 2007 December 12. Review]): 247-257
        • Brand J.S.
        • van der Schouw Y.T.
        Testosterone, SHBG and cardiovascular health in postmenopausal women.
        Int J Impot Res. 2010; 22 ([Epub 2010 January 21. Review]): 91-104
        • Rosenbaum M.
        • Nicolson M.
        • Hirsch J.
        • Heymsfield S.B.
        • Gallagher D.
        • Chu F.
        • et al.
        Effects of gender, body composition, and menopause on plasma concentrations of leptin.
        J Clin Endocrinol Metab. 1996; 81: 3424-3427
        • Messinis I.E.
        • Milingos S.D.
        • Alexandris E.
        • Kariotis I.
        • Kollios G.
        • Seferiadis K.
        Leptin concentrations in normal women following bilateral ovariectomy.
        Hum Reprod. 1999; 14: 913-918
        • Shimizu H.
        • Shimomura Y.
        • Nakanishi Y.
        • Futawatari T.
        • Ohtani K.
        • Sato N.
        • et al.
        Estrogen increases in vivo leptin production in rats and human subjects.
        J Endocrinol. 1997; 154: 285-292
        • Hong S.C.
        • Yoo S.W.
        • Cho G.J.
        • Kim T.
        • Hur J.Y.
        • Park Y.K.
        • et al.
        Correlation between estrogens and serum adipocytokines in premenopausal and postmenopausal women.
        Menopause. 2007; 14: 835-840
        • Di Carlo C.
        • Tommaselli G.A.
        • Di Spiezio Sardo A.
        • Sammartino A.
        • Attianese W.
        • Gargano V.
        • et al.
        Longitudinal evaluation of serum leptin and bone mineral density in early postmenopausal women.
        Menopause. 2007; 14: 450-454
        • Haffner S.M.
        • Mykkanen L.
        • Stern M.P.
        Leptin concentrations in women in the San Antonio Heart Study: effect of menopausal status and postmenopausal hormone replacement therapy.
        Am J Epidemiol. 1997; 146: 581-658
        • Cento R.M.
        • Proto C.
        • Spada R.S.
        • Napolitano V.
        • Ciampelli M.
        • Cucinelli F.
        • et al.
        Leptin levels in menopause: effect of estrogen replacement therapy.
        Horm Res. 1999; 52: 269-273
        • Gower B.A.
        • Nagy T.R.
        • Goran M.I.
        • Smith A.A.
        • Kent E.
        Leptin in postmenopausal women: influence of hormone therapy, insulin, and fat distribution.
        J Clin Endocrinol Metab. 2000; 85: 1770-1775
        • Benetti-Pinto C.
        • Castro N.
        • Grassiotto O.
        • Garmes H.M.
        Leptin and adiponectin blood levels in women with premature ovarian failure and age- and weight-matched women with normal menstrual cycles.
        Menopause. 2010; 17: 174-177
        • Tamakoshi K.
        • Yatsuya H.
        • Wada K.
        • Matsushita K.
        • Otsuka R.
        • Yang P.O.
        • et al.
        The transition to menopause reinforces adiponectin production and its contribution to improvement of insulin-resistant state.
        Clin Endocrinol (Oxf). 2007; 66: 65-71
        • Lee C.G.
        • Carr M.C.
        • Murdoch S.J.
        • Mitchell E.
        • Woods N.F.
        • Wener M.H.
        • et al.
        Adipokines, inflammation and visceral adiposity across the menopausal transition: a prospective study.
        J Clin Endocrinol Metab. 2009; 94 ([Epub 2009 January 6]): 1104-1110
        • Milewicz T.
        • Kostecka A.
        • Rogatko I.
        • Sztefko K.
        • Kwiatkowska-Panek E.
        • Radowick S.
        • et al.
        Plasma levels of total cholesterol, LDL-cholesterol, and HDL-cholesterol in postmenopausal women during 12 months’ oral administration of dydrogesterone or medroxyprogesterone combined with continuous transdermal supplementation of 17A-estradiol.
        Przegl Lek. 2007; 64: 65-69
        • Langrish J.P.
        • Mills N.L.
        • Bath L.E.
        • Warner P.
        • Webb D.J.
        • Kelnar C.J.
        • et al.
        Cardiovascular effects of physiological and standard sex steroid replacement regimens in premature ovarian failure.
        Hypertension. 2009; 53: 805-811
        • Gökmen O.
        • Seçkin N.C.
        • Sener A.B.
        • Ozakşit G.
        • Ekmekçi S.
        A study of premature ovarian failure in Turkish women.
        Gynecol Endocrinol. 1995; 9: 283-287
        • Knauff E.
        • Westerveld H.
        • Goverde A.
        • Eijkemans M.J.
        • Valkenburg O.
        • van Santbrink E.J.
        • et al.
        Lipid profile of women with premature ovarian failure.
        Menopause. 2008; 15 ([Epub 2009 March 30]): 919-923
        • Cooley M.
        • Bakalov V.
        • Bondy C.A.
        Lipid profiles in women with 45X vs 46XX primary ovarian failure.
        JAMA. 2003; 290: 2127-2128
        • Yahata T.
        • Kurabayashi T.
        • Kato R.
        • Yamamoto Y.
        • Fujimaki T.
        • Yasuda M.
        • et al.
        Effect of hormone replacement therapy on lipid metabolism in patients with premature ovarian failure and Turner's syndrome.
        Nippon Sanka Fujinka Gakkai Zasshi. 1994; 46: 1197-1204
        • Papagianni V.
        • Deligeoroglou E.
        • Makrakis E.
        • Botsis D.
        • Creatsas G.
        Response to hormonal treatment of young females with primary or very premature ovarian failure.
        Gynecol Endocrinol. 2011; ([Epub ahead of print])
        • Snowdon D.A.
        • Kane R.L.
        • Beeson W.L.
        • Burke G.L.
        • Sprafka J.M.
        • Potter J.
        • et al.
        Is early natural menopause a biologic marker of health and aging?.
        Am J Public Health. 1989; 79: 709-714
        • Vujovic S.
        • Brincat M.
        • Erel T.
        • Gambacciani M.
        • Lambrinoudaki I.
        • Moen M.H.
        • et al.
        European Menopause and Andropause Society (EMAS) position statement: managing women with premature ovarian failure.
        Maturitas. 2010; 67 ([Epub 2010 June 3]): 91-93
        • Kalantaridou S.N.
        • Naka K.K.
        • Papanikolaou E.
        • Kazakos N.
        • Kravariti M.
        • Calis K.A.
        • et al.
        Impaired endothelial function in young women with premature ovarian failure: normalization with hormone therapy.
        J Clin Endocrinol Metab. 2004; 89: 3907-3913
        • Kalantaridou S.N.
        • Naka K.K.
        • Bechlioulis A.
        • Makrigiannakis A.
        • Michalis L.
        • Chrousos G.P.
        Premature ovarian failure, endothelial dysfunction and estrogen–progestrogen replacement.
        Trends Endocrinol Metab. 2006; 17 ([Epub 2006 March 3]): 101-109
        • Geary N.
        The effect of estrogen on appetite.
        Medscape Womens Health. 1998; 3: 3
        • Musatov S.
        • Chen W.
        • Pfaff D.W.
        • Mobbs C.V.
        • Yang X.J.
        • Clegg D.J.
        • et al.
        Silencing of estrogen receptor alpha in the ventromedial nucleus of hypothalamus leads to metabolic syndrome.
        Proc Natl Acad Sci USA. 2007; 104: 2501-2506
        • Krotkiewski M.
        • Bjorntorp P.
        • Sjostrom L.
        • Smith U.
        Impact of obesity on metabolism in men and women. Importance of regional adipose tissue distribution.
        J Clin Invest. 1983; 72: 1150-1162
        • McTiernan A.
        • Wu L.
        • Chen C.
        • Chlebowski R.
        • Mossavar-Rahmani Y.
        • Modugno F.
        • et al.
        Relation of BMI and physical activity to sex hormones in postmenopausal women.
        Women's Health Initiative Investigators Obesity. 2006; 14: 1662-1677
        • Zhang Y.
        • Nadeau M.
        • Faucher F.
        • Lescelleur O.
        • Biron S.
        • Daris M.
        • et al.
        Progesterone metabolism in adipose cells.
        Mol Cell Endocrinol. 2009; 298 ([Epub 2008 October 15]): 76-83
        • Allan C.A.
        • McLachlan R.I.
        Androgens and obesity.
        Curr Opin Endocrinol Diabetes Obes. 2010; 17: 224-232
        • Michalakis K.
        • Segars J.
        Adiponectin in reproduction: from PCOS to assisted reproduction.
        Fertil Steril. 2010; 94: 6
        • Gosman G.
        • Katcher H.
        • Legro R.
        Obesity and the role of gut and adipose hormones in female reproduction.
        Hum Reprod Update. 2006; 12: 585-601
        • Kilani R.T.
        • Mackova M.
        • Davidge S.T.
        • Winkler-Lowen B.
        • Demianczuk N.
        • Guilbert L.J.
        Endogenous tumor necrosis factor alpha mediates enhanced apoptosis of cultured villous trophoblasts from intrauterine growth-restricted placentae.
        Reproduction. 2007; 133: 257-264
        • Inoue T.
        • Kanzaki H.
        • Iwai M.
        • Imai K.
        • Narukawa S.
        • Higuchi T.
        • et al.
        Tumour necrosis factor alpha inhibits in vitro decidualization of human endometrial stromal cells.
        Hum Reprod. 1994; 9: 2411-2417
        • Nogueiras R.
        • Barreiro M.L.
        • Caminos J.E.
        • Gaytan F.
        • Suomine J.S.
        • Navaro V.M.
        • et al.
        Novel expression of resistin in rat testis: functional role and regulation by nutritional status and hormonal factors.
        J Cell Sci. 2004; 117: 3247-3257
        • Corrigan E.C.
        • Nelson L.M.
        • Bakalov V.K.
        • Yanovski J.A.
        • Vanderhoof V.H.
        • Yanoff L.B.
        • et al.
        Effects of ovarian failure and X-chromosome deletion on body composition and insulin sensitivity in young women.
        Menopause. 2006; 13: 911-916
        • Fatemi H.M.
        • Bourgain C.
        • Donoso P.
        • Blockeel C.
        • Papanikolaou E.G.
        • Popovic-Todorovic B.
        • et al.
        Effect of oral administration of dydrogestrone versus vaginal administration of natural micronised progesterone on the secretory transformation of endometrium and luteal endocrine profile in patients with premature ovarian failure: a proof of concept.
        Hum Reprod. 2007; 22 ([Epub 2007 January 16]): 1260-1263
        • Tartagni M.
        • Cicinelli E.
        • De Pergola G.
        • De Salvia M.A.
        • Lavopa C.
        • Loverro G.
        Effects of pretreatment with estrogens on ovarian stimulation with gonadotropins in women with premature ovarian failure: a randomised, placebo-controlled trial.
        Fertil Steril. 2007; 87 ([Epub 2007 January 29]): 858-861
        • Leite-Silva P.
        • Bedone A.
        • Pinto-Neto A.M.
        • Costa J.V.
        • Costa-Paiva L.
        Factors associated with bone density in young women with karyotypically normal spontaneous premature ovarian failure.
        Arch Gynecol Obstet. 2009; 280 ([Epub 2008 December 23]): 177-181
        • Janse F.
        • Knauff E.A.
        • Niermeijer M.F.
        • Eijkemans M.J.
        • Laven J.S.
        • Lambalk C.B.
        • et al.
        Dutch Premature Ovarian Failure Consortium. Similar phenotype characteristics comparing familial and sporadic premature ovarian failure.
        Menopause. 2010; 17: 758-765
        • Uygur D.
        • Sengül O.
        • Bayar D.
        • Erdinç S.
        • Batioğlu S.
        • Mollamahmutoglu L.
        Bone loss in young women with premature ovarian failure.
        Arch Gynecol Obstet. 2005; 273 ([Epub 2005 July 11]): 17-19
        • Finucane M.M.
        • Stevens G.A.
        • Cowan M.J.
        • Danaei G.
        • Lin J.K.
        • Paciorek C.J.
        • et al.
        National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9.1 million participants.
        Lancet. 2011; 377 ([Epub 2011 February 3]): 557-567